United States

VolitionRX Ltd (VNRX)

Track

Track

VolitionRX Ltd has seen no insider trading activity within the last three months. The most recent transactions occurred in early January 2024, involving sales by Eight Corp Ltd. Historical records indicate various buying and selling patterns by company officials, with the latest recorded movement dating back over a year.
Ticker: VNRX Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for VolitionRX Ltd. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.9
Eight Corp Ltd Large shareholder
Transaction date
Sale
Price
297.54
Quantity 64,544 -16.8%
Value US$2,747,324
1.9
Eight Corp Ltd Large shareholder
Transaction date
Sale
Price
493.01
Quantity 83,809 +49.1%
Value US$4,904,977
2.8
TERRELL JASON BRADLEY MD Chief Medical Officer Officer
Transaction date
Sale
Price
87.06
Quantity 92,949 -47.1%
Value US$4,883,606
1.7
Innes Guy Archibald Non-Executive Director
Transaction date
Purchase
Price
3.47
Quantity 50,000 +3.4%
Value US$173,500
2.3
Nguyen Kim Non-Executive Director
Transaction date
Purchase
Price
3.20
Quantity 2,000 +400.0%
Value US$6,400
1.7
Innes Guy Archibald Non-Executive Director
Transaction date
Purchase
Price
3.29
Quantity 100,000 +7.2%
Value US$329,000
2.8
TERRELL JASON BRADLEY MD Chief Medical Officer Officer
Transaction date
Sale
Price
5.37
Quantity 10,000 -22.2%
Value US$53,700
2.8
TERRELL JASON BRADLEY MD Chief Medical Officer Officer
Transaction date
Sale
Price
3.40
Quantity 10,000 -18.2%
Value US$34,000
2.8
TERRELL JASON BRADLEY MD Chief Medical Officer Officer
Transaction date
Sale
Price
3.45
Quantity 200 -0.4%
Value US$690
2.8
TERRELL JASON BRADLEY MD Chief Medical Officer Officer
Transaction date
Sale
Price
3.35
Quantity 3,229 -5.5%
Value US$10,817
2.8
TERRELL JASON BRADLEY MD Chief Medical Officer Officer
Transaction date
Sale
Price
3.40
Quantity 1,571 -2.6%
Value US$5,341
2.8
TERRELL JASON BRADLEY MD Chief Medical Officer Officer
Transaction date
Sale
Price
3.23
Quantity 19,500 -35.8%
Value US$62,985
2.7
Faulkes Martin Charles Non-Executive Director
Transaction date
Sale
Price
3.21
Quantity 65,000 -4.1%
Value US$208,650
Reynolds Cameron John President and CEO Executive Director
Transaction date
Purchase
Price
2.75
Quantity 4,000 +0.4%
Value US$11,000
Reynolds Cameron John President and CEO Executive Director
Transaction date
Purchase
Price
4.24
Quantity 1,100 +0.1%
Value US$4,664
1.9
Eight Corp Ltd Large shareholder
Transaction date
Purchase
Price
5.69
Quantity 50,000 +0.4%
Value US$284,570
1.9
Eight Corp Ltd Large shareholder
Transaction date
Sale
Price
6.03
Quantity 46,238 -0.4%
Value US$278,792
Faulkes Martin Charles Non-Executive Director
Transaction date
Purchase
Price
3.75
Quantity 10,000 +0.6%
Value US$37,500
Faulkes Martin Charles Non-Executive Director
Transaction date
Purchase
Price
3.94
Quantity 50,000 +3.3%
Value US$197,000
2.7
Faulkes Martin Charles
Transaction date
Purchase
Price
3.14
Quantity 10,000 +0.7%
Value US$31,400
2.7
Faulkes Martin Charles
Transaction date
Purchase
Price
3.10
Quantity 69,269 +4.9%
Value US$214,734
2.7
Faulkes Martin Charles
Transaction date
Purchase
Price
3.02
Quantity 70,731 +5.2%
Value US$213,608
Innes Guy Archibald Non-Executive Director
Transaction date
Purchase
Price
2.00
Quantity 49,826 +3.8%
Value US$99,652
Innes Guy Archibald Non-Executive Director
Transaction date
Purchase
Price
1.99
Quantity 14 +0.0%
Value US$28
Innes Guy Archibald Non-Executive Director
Transaction date
Purchase
Price
1.97
Quantity 7 +0.0%
Value US$14
Innes Guy Archibald Non-Executive Director
Transaction date
Purchase
Price
1.95
Quantity 153 +0.0%
Value US$298
Rootsaert Rodney Gerard Secretary Officer
Transaction date
Purchase
Price
1.91
Quantity 5,000 +103.6%
Value US$9,550
Reynolds Cameron John President and CEO Executive Director
Transaction date
Purchase
Price
1.91
Quantity 6,500 +0.6%
Value US$12,415
Vanston David Cecil CHIEF FINANCIAL OFFICER
Transaction date
Purchase
Price
2.84
Quantity 2,750 +inf%
Value US$7,810
Reynolds Cameron John President and CEO Executive Director
Transaction date
Purchase
Price
2.77
Quantity 3,630 +0.4%
Value US$10,055
Rootsaert Rodney Gerard Secretary
Transaction date
Purchase
Price
2.77
Quantity 3,630 +0.4%
Value US$10,055
KRATOCHVIL DAVID MATTHEW Chief Financial Officer Officer
Transaction date
Purchase
Price
5.00
Quantity 10,000 +inf%
Value US$50,000
Reynolds Cameron John President and CEO Executive Director
Transaction date
Sale
Price
3.54
Quantity 3,390 -10.5%
Value US$12,001
Reynolds Cameron John President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
3.41
Quantity 100 +0.0%
Value US$341
Reynolds Cameron John President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
3.32
Quantity 1,400 +0.1%
Value US$4,648
Innes Guy Archibald Non-Executive Director
Transaction date
Purchase
Price
3.75
Quantity 50,000 +4.5%
Value US$187,500
Innes Guy Archibald Non-Executive Director
Transaction date
Purchase
Price
18,748.40
Quantity 8,522 +0.8%
Value US$159,773,865
Colman Alan Non-Executive Director
Transaction date
Purchase
Price
7,000.00
Quantity 3,182 +6.3%
Value US$22,274,000
Faulkes Martin Charles Non-Executive Director
Transaction date
Purchase
Price
2.16
Quantity 5,000 +0.5%
Value US$10,800
Rootsaert Rodney Gerard Secretary Officer
Transaction date
Sale
Price
1.80
Quantity 6,000 -0.6%
Value US$10,800
Rootsaert Rodney Gerard Secretary Officer
Transaction date
Sale
Price
1.80
Quantity 10,000 -0.5%
Value US$18,000
Rootsaert Rodney Gerard Secretary Officer
Transaction date
Sale
Price
1.80
Quantity 12,000 -0.6%
Value US$21,600
Innes Guy Archibald Non-Executive Director
Transaction date
Purchase
Price
4,206.72
Quantity 3,572 +0.3%
Value US$15,026,404
Innes Guy Archibald Non-Executive Director
Transaction date
Purchase
Price
45,793.28
Quantity 38,884 +3.6%
Value US$1,780,625,900
Innes Guy Archibald Non-Executive Director
Transaction date
Purchase
Price
9,999.90
Quantity 4,878 +0.5%
Value US$48,779,512
Innes Guy Archibald Non-Executive Director
Transaction date
Purchase
Price
271,102.70
Quantity 132,246 +14.2%
Value US$35,852,247,664
Innes Guy Archibald Non-Executive Director
Transaction date
Purchase
Price
1,898.10
Quantity 999 +0.1%
Value US$1,896,202
Innes Guy Archibald Non-Executive Director
Transaction date
Purchase
Price
7,951.14
Quantity 4,878 +0.5%
Value US$38,785,661
Innes Guy Archibald Non-Executive Director
Transaction date
Purchase
Price
114,583.22
Quantity 57,292 +6.6%
Value US$6,564,701,840
THACHUK MARY ANNE Secretary Treasurer Officer
Transaction date
Purchase
Price
0.05
Quantity 20,000 +inf%
Value US$1,000
THACHUK E DEL CEO and President Executive Director
Transaction date
Purchase
Price
0.05
Quantity 100,000 +inf%
Value US$5,000
Brooke Brian Gordon Chief Financial Officer Executive Director
Transaction date
Purchase
Price
0.05
Quantity 50,000 +inf%
Value US$2,500
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-01-03 2024-01-02 S Sale
1.9
Eight Corp Ltd
Large shareholder
64,544 -16.8%
297.54
US$2,747,324 		64,544 -16.8% 297.54 US$2,747,324
2023-12-20 2023-12-15 S Sale
1.9
Eight Corp Ltd
Large shareholder
83,809 +49.1%
493.01
US$4,904,977 		83,809 +49.1% 493.01 US$4,904,977
2021-06-02 2021-05-28 S Sale
2.8
TERRELL JASON BRADLEY MD

Chief Medical Officer

Officer
92,949 -47.1%
87.06
US$4,883,606 		92,949 -47.1% 87.06 US$4,883,606
2021-05-18 2021-05-17 B Purchase
1.7
Innes Guy Archibald
Non-Executive Director
50,000 +3.4%
3.47
US$173,500 		50,000 +3.4% 3.47 US$173,500
2021-05-18 2021-05-14 B Purchase
2.3
Nguyen Kim
Non-Executive Director
2,000 +400.0%
3.20
US$6,400 		2,000 +400.0% 3.20 US$6,400
2021-05-18 2021-05-14 B Purchase
1.7
Innes Guy Archibald
Non-Executive Director
100,000 +7.2%
3.29
US$329,000 		100,000 +7.2% 3.29 US$329,000
2021-02-08 2021-02-05 S Sale
2.8
TERRELL JASON BRADLEY MD

Chief Medical Officer

Officer
10,000 -22.2%
5.37
US$53,700 		10,000 -22.2% 5.37 US$53,700
2020-12-04 2020-12-02 S Sale
2.8
TERRELL JASON BRADLEY MD

Chief Medical Officer

Officer
10,000 -18.2%
3.40
US$34,000 		10,000 -18.2% 3.40 US$34,000
2020-11-19 2020-11-18 S Sale
2.8
TERRELL JASON BRADLEY MD

Chief Medical Officer

Officer
200 -0.4%
3.45
US$690 		200 -0.4% 3.45 US$690
2020-11-19 2020-11-18 S Sale
2.8
TERRELL JASON BRADLEY MD

Chief Medical Officer

Officer
3,229 -5.5%
3.35
US$10,817 		3,229 -5.5% 3.35 US$10,817
2020-11-19 2020-11-17 S Sale
2.8
TERRELL JASON BRADLEY MD

Chief Medical Officer

Officer
1,571 -2.6%
3.40
US$5,341 		1,571 -2.6% 3.40 US$5,341
2020-09-18 2020-09-15 S Sale
2.8
TERRELL JASON BRADLEY MD

Chief Medical Officer

Officer
19,500 -35.8%
3.23
US$62,985 		19,500 -35.8% 3.23 US$62,985
2020-09-10 2020-09-09 S Sale
2.7
Faulkes Martin Charles
Non-Executive Director
65,000 -4.1%
3.21
US$208,650 		65,000 -4.1% 3.21 US$208,650
2020-05-22 2020-05-22 B Purchase
Reynolds Cameron John

President and CEO

Executive Director
4,000 +0.4%
2.75
US$11,000 		4,000 +0.4% 2.75 US$11,000
2019-12-06 2019-12-05 B Purchase Reynolds Cameron John

President and CEO

Executive Director
1,100 +0.1%
4.24
US$4,664 		1,100 +0.1% 4.24 US$4,664
2019-10-18 2019-10-01 B Purchase
1.9
Eight Corp Ltd
Large shareholder
50,000 +0.4%
5.69
US$284,570 		50,000 +0.4% 5.69 US$284,570
2019-09-30 2019-09-26 S Sale
1.9
Eight Corp Ltd
Large shareholder
46,238 -0.4%
6.03
US$278,792 		46,238 -0.4% 6.03 US$278,792
2019-08-28 2019-08-27 B Purchase Faulkes Martin Charles Non-Executive Director
10,000 +0.6%
3.75
US$37,500 		10,000 +0.6% 3.75 US$37,500
2019-08-16 2019-08-15 B Purchase Faulkes Martin Charles Non-Executive Director
50,000 +3.3%
3.94
US$197,000 		50,000 +3.3% 3.94 US$197,000
2019-06-13 2019-06-11 B Purchase
2.7
Faulkes Martin Charles
10,000 +0.7%
3.14
US$31,400 		10,000 +0.7% 3.14 US$31,400
2019-06-13 2019-06-11 B Purchase
2.7
Faulkes Martin Charles
69,269 +4.9%
3.10
US$214,734 		69,269 +4.9% 3.10 US$214,734
2019-06-12 2019-06-10 B Purchase
2.7
Faulkes Martin Charles
70,731 +5.2%
3.02
US$213,608 		70,731 +5.2% 3.02 US$213,608
2018-08-20 2018-08-16 B Purchase Innes Guy Archibald Non-Executive Director
49,826 +3.8%
2.00
US$99,652 		49,826 +3.8% 2.00 US$99,652
2018-08-20 2018-08-16 B Purchase Innes Guy Archibald Non-Executive Director
14 +0.0%
1.99
US$28 		14 +0.0% 1.99 US$28
2018-08-20 2018-08-16 B Purchase Innes Guy Archibald Non-Executive Director
7 +0.0%
1.97
US$14 		7 +0.0% 1.97 US$14
2018-08-20 2018-08-16 B Purchase Innes Guy Archibald Non-Executive Director
153 +0.0%
1.95
US$298 		153 +0.0% 1.95 US$298
2018-08-17 2018-08-16 B Purchase Rootsaert Rodney Gerard

Secretary

Officer
5,000 +103.6%
1.91
US$9,550 		5,000 +103.6% 1.91 US$9,550
2018-08-17 2018-08-16 B Purchase Reynolds Cameron John

President and CEO

Executive Director
6,500 +0.6%
1.91
US$12,415 		6,500 +0.6% 1.91 US$12,415
2017-09-19 2017-09-19 B Purchase Vanston David Cecil

CHIEF FINANCIAL OFFICER
2,750 +inf%
2.84
US$7,810 		2,750 +inf% 2.84 US$7,810
2017-08-17 2017-08-16 B Purchase Reynolds Cameron John

President and CEO

Executive Director
3,630 +0.4%
2.77
US$10,055 		3,630 +0.4% 2.77 US$10,055
2017-08-17 2017-08-16 B Purchase Rootsaert Rodney Gerard

Secretary
3,630 +0.4%
2.77
US$10,055 		3,630 +0.4% 2.77 US$10,055
2016-10-06 2016-10-05 B Purchase KRATOCHVIL DAVID MATTHEW

Chief Financial Officer

Officer
10,000 +inf%
5.00
US$50,000 		10,000 +inf% 5.00 US$50,000
2016-05-24 2016-05-20 S Sale Reynolds Cameron John

President and CEO

Executive Director
3,390 -10.5%
3.54
US$12,001 		3,390 -10.5% 3.54 US$12,001
2015-05-18 2015-05-15 B Purchase Reynolds Cameron John

President and CEO

Executive Director Large shareholder
100 +0.0%
3.41
US$341 		100 +0.0% 3.41 US$341
2015-05-18 2015-05-15 B Purchase Reynolds Cameron John

President and CEO

Executive Director Large shareholder
1,400 +0.1%
3.32
US$4,648 		1,400 +0.1% 3.32 US$4,648
2015-02-13 2015-02-11 B Purchase Innes Guy Archibald Non-Executive Director
50,000 +4.5%
3.75
US$187,500 		50,000 +4.5% 3.75 US$187,500
2014-09-29 2014-09-24 B Purchase Innes Guy Archibald Non-Executive Director
8,522 +0.8%
18,748.40
US$159,773,865 		8,522 +0.8% 18,748.40 US$159,773,865
2014-09-29 2014-09-24 B Purchase Colman Alan Non-Executive Director
3,182 +6.3%
7,000.00
US$22,274,000 		3,182 +6.3% 7,000.00 US$22,274,000
2014-09-17 2014-09-15 B Purchase Faulkes Martin Charles Non-Executive Director
5,000 +0.5%
2.16
US$10,800 		5,000 +0.5% 2.16 US$10,800
2014-09-03 2014-09-03 S Sale Rootsaert Rodney Gerard

Secretary

Officer
6,000 -0.6%
1.80
US$10,800 		6,000 -0.6% 1.80 US$10,800
2014-09-03 2014-09-03 S Sale Rootsaert Rodney Gerard

Secretary

Officer
10,000 -0.5%
1.80
US$18,000 		10,000 -0.5% 1.80 US$18,000
2014-09-03 2014-09-03 S Sale Rootsaert Rodney Gerard

Secretary

Officer
12,000 -0.6%
1.80
US$21,600 		12,000 -0.6% 1.80 US$21,600
2014-03-12 2014-03-10 B Purchase Innes Guy Archibald Non-Executive Director
3,572 +0.3%
4,206.72
US$15,026,404 		3,572 +0.3% 4,206.72 US$15,026,404
2014-03-12 2014-03-10 B Purchase Innes Guy Archibald Non-Executive Director
38,884 +3.6%
45,793.28
US$1,780,625,900 		38,884 +3.6% 45,793.28 US$1,780,625,900
2013-12-04 2013-12-02 B Purchase Innes Guy Archibald Non-Executive Director
4,878 +0.5%
9,999.90
US$48,779,512 		4,878 +0.5% 9,999.90 US$48,779,512
2013-12-04 2013-11-25 B Purchase Innes Guy Archibald Non-Executive Director
132,246 +14.2%
271,102.70
US$35,852,247,664 		132,246 +14.2% 271,102.70 US$35,852,247,664
2013-11-18 2013-11-14 B Purchase Innes Guy Archibald Non-Executive Director
999 +0.1%
1,898.10
US$1,896,202 		999 +0.1% 1,898.10 US$1,896,202
2013-11-18 2013-11-14 B Purchase Innes Guy Archibald Non-Executive Director
4,878 +0.5%
7,951.14
US$38,785,661 		4,878 +0.5% 7,951.14 US$38,785,661
2013-11-18 2013-03-25 B Purchase Innes Guy Archibald Non-Executive Director
57,292 +6.6%
114,583.22
US$6,564,701,840 		57,292 +6.6% 114,583.22 US$6,564,701,840
2005-11-28 2005-09-30 B Purchase THACHUK MARY ANNE

Secretary Treasurer

Officer
20,000 +inf%
0.05
US$1,000 		20,000 +inf% 0.05 US$1,000
2005-11-28 2005-09-30 B Purchase THACHUK E DEL

CEO and President

Executive Director
100,000 +inf%
0.05
US$5,000 		100,000 +inf% 0.05 US$5,000
2005-11-23 2005-09-30 B Purchase Brooke Brian Gordon

Chief Financial Officer

Executive Director
50,000 +inf%
0.05
US$2,500 		50,000 +inf% 0.05 US$2,500
Explore more

More insider trading research around VolitionRX Ltd

More insider trades in United States
Insider trading in North America